These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19403648)

  • 1. PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line.
    Nofziger C; Brown KK; Smith CD; Harrington W; Murray D; Bisi J; Ashton TT; Maurio FP; Kalsi K; West TA; Baines D; Blazer-Yost BL
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F55-62. PubMed ID: 19403648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptors reduces CFTR-mediated Cl(-) transport in kidney collecting duct cells.
    Raksaseri P; Chatsudthipong V; Muanprasat C; Soodvilai S
    Am J Physiol Renal Physiol; 2013 Aug; 305(4):F583-91. PubMed ID: 23720350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.
    Pavlov TS; Levchenko V; Karpushev AV; Vandewalle A; Staruschenko A
    Mol Pharmacol; 2009 Dec; 76(6):1333-40. PubMed ID: 19752200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin regulates the phosphorylation state of AMP-activated protein kinase (AMPK) in MDCK-C7 cells.
    Nofziger C; Kalsi K; West TA; Baines D; Blazer-Yost BL
    Cell Physiol Biochem; 2008; 22(5-6):487-96. PubMed ID: 19088430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
    Bajwa PJ; Lee JW; Straus DS; Lytle C
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G82-9. PubMed ID: 19443733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ-induced stimulation of amiloride-sensitive sodium current in renal collecting duct principal cells is serum and insulin dependent.
    Chraïbi A; Renauld S
    Cell Physiol Biochem; 2014; 33(3):581-93. PubMed ID: 24603133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.
    Borsting E; Cheng VP; Glass CK; Vallon V; Cunard R
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F540-51. PubMed ID: 22169011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the ion transport responses to ADH in the MDCK-C7 cell line.
    Lahr TF; Record RD; Hoover DK; Hughes CL; Blazer-Yost BL
    Pflugers Arch; 2000 Mar; 439(5):610-7. PubMed ID: 10764221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in madin-darby canine kidney cells.
    Moyer BD; Loffing J; Schwiebert EM; Loffing-Cueni D; Halpin PA; Karlson KH; Ismailov II; Guggino WB; Langford GM; Stanton BA
    J Biol Chem; 1998 Aug; 273(34):21759-68. PubMed ID: 9705313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
    Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
    Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.
    Artunc F; Sandulache D; Nasir O; Boini KM; Friedrich B; Beier N; Dicks E; Pötzsch S; Klingel K; Amann K; Blazer-Yost BL; Scholz W; Risler T; Kuhl D; Lang F
    Pflugers Arch; 2008 May; 456(2):425-36. PubMed ID: 18172605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats.
    Chen L; Yang B; McNulty JA; Clifton LG; Binz JG; Grimes AM; Strum JC; Harrington WW; Chen Z; Balon TW; Stimpson SA; Brown KK
    J Pharmacol Exp Ther; 2005 Feb; 312(2):718-25. PubMed ID: 15475592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
    Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
    BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney.
    Wilson SM; Mansley MK; Getty J; Husband EM; Inglis SK; Hansen MK
    Br J Pharmacol; 2010 Feb; 159(3):678-88. PubMed ID: 20105179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
    Li H; Findlay IA; Sheppard DN
    Kidney Int; 2004 Nov; 66(5):1926-38. PubMed ID: 15496164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
    Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
    Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor γ prevents the production of NOD-like receptor family, pyrin domain containing 3 inflammasome and interleukin 1β in HK-2 renal tubular epithelial cells stimulated by monosodium urate crystals.
    Hong W; Hu S; Zou J; Xiao J; Zhang X; Fu C; Feng X; Ye Z
    Mol Med Rep; 2015 Oct; 12(4):6221-6. PubMed ID: 26238426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultured human periosteal-derived cells have inducible adipogenic activity and can also differentiate into osteoblasts in a perioxisome proliferator-activated receptor-mediated fashion.
    Hah YS; Joo HH; Kang YH; Park BW; Hwang SC; Kim JW; Sung IY; Rho GJ; Woo DK; Byun JH
    Int J Med Sci; 2014; 11(11):1116-28. PubMed ID: 25170294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.